Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 53Radiotherapy 36Fluorouracil 16Paclitaxel 15Radiotherapy, Intensity-Modulated 14Docetaxel 12Cetuximab 12Carboplatin 12Platinum 6Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 5Radiation 4Polymerase Chain Reaction 4Nimorazole 4Drug Therapy 4Chemotherapy, Adjuvant 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Taxes 3Magnetic Resonance Spectroscopy 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Afatinib 3vandetanib 2pembrolizumab 2dehydroftorafur 2Surgical Procedures, Operative 2Specimen Handling 2Reverse Transcriptase Polymerase Chain Reaction 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Resistance Training × Head & Neck × Clear all
NCT01025518 2016-11-29

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Danish Head and Neck Cancer Group

Phase NA Completed
30 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡